CIRM Funded Clinical Trials

Personalized antisense oligonucleotide therapy for rare pediatric genetic disease: SCN2A

Disease Area:
Neurological Disorders, Other
Investigator:
CIRM Grant:
CLIN2-15085 (Pre-Active)
Award Value:
$985,713.00
Trial Sponsor:
University of California, San Diego
Trial Stage:
Phase 1/2
Trial Status:
Launching
Targeted Enrollment:
N/A

CIRM Clinical Trial Resources


Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox


Video on Stem Cell Trials


Other Resources

ISSCR Patient Website

ClinicalTrials.gov